Two years of adjuvant tamoxifen in premenopausal patients with breast cancer: A randomised, controlled trial with long-term follow-up
Lisa Rydén, Per Ebbe Jönsson, Gunilla Chebil, Monika Dufmats, Mårten Fernö, Karin Jirström, Ann Christin Källström, Göran Landberg, Olle Stål, Sten Thorstenson, Bo Nordenskjöld
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Two years of adjuvant tamoxifen in premenopausal patients with breast cancer: A randomised, controlled trial with long-term follow-up'. Together they form a unique fingerprint.